Genetic and environmental aspect of polycystic ovary syndrome
- 1 November 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Endocrinological Investigation
- Vol. 26 (11), 1151-1159
- https://doi.org/10.1007/bf03345266
Abstract
Polycystic ovary syndrome (PCOS) is a heterogeneous syndrome determined in most patients by the association of two main factors: hyperandrogenism and insulin resistance. These characters are probably independent of each other and seem to be inherited by several different mechanisms. In some patients homozygous gene alteration has been found but in most patients PCOS seems to be determined by the association of gene polymorphisms that are common in the general population but alone are unable to determine phenotypic consequences. Alteration of genes that regulate the initial steps of ovarian steroidogenesis is probably the main causal factor of hyperandrogenism. Insulin resistance may be the result of many different gene alterations including insulin receptor substrate (IRS)-1 and 2, calpain-10 and peroxisome proliferator-activated receptor γ (PPARγ). Some polymorphisms may be protective against other gene alterations. Insulin sensitivity is also modified by socioeconomic and cultural factors that influence quantity and quality of food and energy expenditure. However, even eating behavior and weight response to food intake may be under genetic regulation. Different combinations of multiple gene polymorphisms and of environmental factors explain the heterogeneity of PCOS.Keywords
This publication has 78 references indexed in Scilit:
- The Molecular Phenotype of Polycystic Ovary Syndrome (PCOS) Theca Cells and New Candidate PCOS Genes Defined by Microarray AnalysisJournal of Biological Chemistry, 2003
- Lack of association between C-850T polymorphism of the gene encoding tumor necrosis factor-α and polycystic ovary syndromeGynecological Endocrinology, 2002
- Digenic inheritance of severe insulin resistance in a human pedigreeNature Genetics, 2002
- Anti-androgens for the treatment of hirsutismExpert Opinion on Investigational Drugs, 2002
- Role of the pentanucleotide (tttta)n polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutismFertility and Sterility, 2001
- Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitusNature Genetics, 2000
- Calpain: A Protease in Search of a Function?Biochemical and Biophysical Research Communications, 1998
- Association of insulin gene VNTR polymorphism with polycystic ovary syndromeThe Lancet, 1997
- Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.JCI Insight, 1995
- Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretionEndocrine Reviews, 1995